Manasi Tannu

ORCID: 0000-0001-5576-3257
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Peripheral Artery Disease Management
  • Atrial Fibrillation Management and Outcomes
  • Venous Thromboembolism Diagnosis and Management
  • Heart Failure Treatment and Management
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Chromatin Remodeling and Cancer
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics
  • Ubiquitin and proteasome pathways
  • Coronary Interventions and Diagnostics
  • Cardiac Arrest and Resuscitation
  • Mechanical Circulatory Support Devices
  • Autophagy in Disease and Therapy
  • Cardiac Ischemia and Reperfusion
  • Lipoproteins and Cardiovascular Health
  • Muscle Physiology and Disorders
  • Peptidase Inhibition and Analysis
  • Congenital Diaphragmatic Hernia Studies
  • Mitochondrial Function and Pathology
  • Endoplasmic Reticulum Stress and Disease
  • Mechanisms of cancer metastasis
  • Central Venous Catheters and Hemodialysis
  • Inflammatory Myopathies and Dermatomyositis
  • Parkinson's Disease and Spinal Disorders
  • Cardiac Arrhythmias and Treatments

Duke University
2022-2025

Clinical Research Institute
2024-2025

Duke University Health System
2023-2025

Duke University Hospital
2024

Baylor College of Medicine
2021

Emory University
2020-2021

Emory University Hospital
2020

Shandong Provincial Hospital
2017

Shandong University
2017

Indiana University School of Medicine
2016

Results from the COORDINATE-Diabetes trial (Coordinating Cardiology Clinics Randomized Trial of Interventions to Improve Outcomes - Diabetes) demonstrated that a multifaceted, clinic-based intervention increased prescription evidence-based medical therapies participants with type 2 diabetes and atherosclerotic cardiovascular disease. This secondary analysis assessed whether success was consistent across sex, race, ethnicity.

10.1161/circulationaha.124.068962 article EN Circulation 2024-06-27

Statin-induced necrotizing autoimmune myopathy (SINAM) is an exceptionally rare yet devastating complication of statin therapy that can occur at any time after initiation. It should be considered in patients who develop proximal muscle weakness and marked elevated creatine phosphokinase while taking therapy. (Level Difficulty: Beginner.)

10.1016/j.jaccas.2019.12.019 article EN cc-by-nc-nd JACC Case Reports 2020-02-26

The prevalence of serotonin syndrome increases over the past several years as more serotonergic medications are being used in clinical practice. It is a potentially lethal condition caused by excessive activity. Common causes use prescription medications, illicit drugs, or combination substances, leading to an increase activity central and peripheral nervous system. symptoms range from mild severe. We report case 25-year-old woman with polysubstance abuse, including cocaine, who presented...

10.1177/2324709620936832 article EN cc-by Journal of Investigative Medicine High Impact Case Reports 2020-01-01

Abstract Background Among anticoagulated patients with atrial fibrillation (AF), intracranial hemorrhage (ICH) is the leading cause of bleeding-related death and disability. The COMBINE-AF database has patient-level data from four major randomized-controlled trials [ROCKET-AF (rivaroxaban), RE-LY (dabigatran), ENGAGE-TIMI 48 (edoxaban), ARISTOTLE (apixaban)] direct oral anticoagulants (DOACs) versus warfarin in AF. Purpose/Methods We investigated rates, predictors, mortality ICH randomized...

10.1093/eurheartj/ehae666.606 article EN European Heart Journal 2024-10-01
Coming Soon ...